These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
119 related items for PubMed ID: 32193104
1. The pterocarpanquinone LQB 118 inhibits inflammation triggered by zymosan in vivo and in vitro. Lima ÉA, Cavalcante-Silva LHA, Carvalho DCM, Netto CD, Costa PRR, Rodrigues-Mascarenhas S. Int Immunopharmacol; 2020 Jun; 83():106399. PubMed ID: 32193104 [Abstract] [Full Text] [Related]
2. Anti-inflammatory properties of pterocarpanquinone LQB-118 in mice. Riça IG, Netto CD, Rennó MN, Abreu PA, Costa PRR, da Silva AJM, Cavalcante MCM. Bioorg Med Chem; 2016 Sep 15; 24(18):4415-4423. PubMed ID: 27492193 [Abstract] [Full Text] [Related]
4. Protective effect of chloral hydrate against lipopolysaccharide/D-galactosamine-induced acute lethal liver injury and zymosan-induced peritonitis in mice. Pan Q, Liu Y, Zheng J, Lu X, Wu S, Zhu P, Fu N. Int Immunopharmacol; 2010 Aug 15; 10(8):967-77. PubMed ID: 20669364 [Abstract] [Full Text] [Related]
5. Vitexin reduces neutrophil migration to inflammatory focus by down-regulating pro-inflammatory mediators via inhibition of p38, ERK1/2 and JNK pathway. Rosa SI, Rios-Santos F, Balogun SO, Martins DT. Phytomedicine; 2016 Jan 15; 23(1):9-17. PubMed ID: 26902402 [Abstract] [Full Text] [Related]
6. Forsythoside A Modulates Zymosan-Induced Peritonitis in Mice. Zhang XT, Ding Y, Kang P, Zhang XY, Zhang T. Molecules; 2018 Mar 06; 23(3):. PubMed ID: 29509714 [Abstract] [Full Text] [Related]
7. Icaritin exhibits anti-inflammatory effects in the mouse peritoneal macrophages and peritonitis model. Lai X, Ye Y, Sun C, Huang X, Tang X, Zeng X, Yin P, Zeng Y. Int Immunopharmacol; 2013 May 06; 16(1):41-9. PubMed ID: 23566810 [Abstract] [Full Text] [Related]
8. Peritoneal mesothelial cells produce inflammatory related cytokines. Yao V, Platell C, Hall JC. ANZ J Surg; 2004 Nov 06; 74(11):997-1002. PubMed ID: 15550091 [Abstract] [Full Text] [Related]
9. Evaluation of anti-inflammatory and mechanism of action of extract of Macrosiphonia longiflora (Desf.) Müll. Arg. da Silva AO, Damaceno Alves A, Almeida DA, Balogun SO, de Oliveira RG, Aires Aguiar A, Soares IM, Marson-Ascêncio PG, Ascêncio SD, de Oliveira Martins DT. J Ethnopharmacol; 2014 Jun 11; 154(2):319-29. PubMed ID: 24681039 [Abstract] [Full Text] [Related]
10. Modulation of zymosan-induced peritonitis by riboflavin co-injection, pre-injection or post-injection in male Swiss mice. Mazur-Bialy AI, Kolaczkowska E, Plytycz B. Life Sci; 2012 Dec 17; 91(25-26):1351-7. PubMed ID: 23123448 [Abstract] [Full Text] [Related]
11. The orally active pterocarpanquinone LQB-118 exhibits cytotoxicity in prostate cancer cell and tumor models through cellular redox stress. Martino T, Kudrolli TA, Kumar B, Salviano I, Mencalha A, Coelho MGP, Justo G, Costa PRR, Sabino KCC, Lupold SE. Prostate; 2018 Feb 17; 78(2):140-151. PubMed ID: 29105806 [Abstract] [Full Text] [Related]
17. Temporin L-derived peptide as a regulator of the acute inflammatory response in zymosan-induced peritonitis. Bellavita R, Raucci F, Merlino F, Piccolo M, Ferraro MG, Irace C, Santamaria R, Iqbal AJ, Novellino E, Grieco P, Mascolo N, Maione F. Biomed Pharmacother; 2020 Mar 17; 123():109788. PubMed ID: 31865142 [Abstract] [Full Text] [Related]
18. Myeloperoxidase negatively regulates the expression of proinflammatory cytokines and chemokines by zymosan-induced mouse neutrophils. Endo D, Saito T, Umeki Y, Suzuki K, Aratani Y. Inflamm Res; 2016 Feb 17; 65(2):151-9. PubMed ID: 26573963 [Abstract] [Full Text] [Related]
19. A new acyl derivative of sulfadimethoxine inhibits phagocyte oxidative burst and ameliorates inflammation in a mice model of zymosan-induced generalised inflammation. Baig TA, Haniffa HM, Siddiqui H, Shah SF, Jabeen A. Inflammopharmacology; 2023 Dec 17; 31(6):3303-3316. PubMed ID: 37971604 [Abstract] [Full Text] [Related]
20. Anti-inflammatory effects of LASSBio-998, a new drug candidate designed to be a p38 MAPK inhibitor, in an experimental model of acute lung inflammation. Brando Lima AC, Machado AL, Simon P, Cavalcante MM, Rezende DC, Sperandio da Silva GM, Nascimento PG, Quintas LE, Cunha FQ, Barreiro EJ, Lima LM, Koatz VL. Pharmacol Rep; 2011 Dec 17; 63(4):1029-39. PubMed ID: 22001991 [Abstract] [Full Text] [Related] Page: [Next] [New Search]